Cargando…
Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice
Spleen Tyrosine Kinase (SYK) is a critical immune signaling molecule and therapeutic target. We identified damaging monoallelic SYK variants in six patients with immune deficiency, systemic disease such as colitis, arthritis and skin inflammation, and diffuse large B cell lymphomas. The SYK variants...
Ejemplares similares
-
Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications
por: Aschenbrenner, Dominik, et al.
Publicado: (2022) -
The E3 ubiquitin ligase UBR5 interacts with TTC7A and may be associated with very early onset inflammatory bowel disease
por: Dhingani, Neel, et al.
Publicado: (2020) -
Valosin-containing protein-regulated endoplasmic reticulum stress causes NOD2-dependent inflammatory responses
por: Ghalandary, Maryam, et al.
Publicado: (2022) -
Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease
por: Bosa, Luca, et al.
Publicado: (2021) -
Advanced Understanding of Monogenic Inflammatory Bowel Disease
por: Nambu, Ryusuke, et al.
Publicado: (2021)